Stockscreener 앱 받기
2.36
5.83%
0.13
시간 외 거래:
2.37
0.01
+0.42%
전일 마감가:
$2.23
열려 있는:
$2.29
하루 거래량:
3,375
Relative Volume:
0.12
시가총액:
$96.96M
수익:
-
순이익/손실:
$-7.92M
주가수익비율:
-7.8667
EPS:
-0.3
순현금흐름:
$-7.05M
1주 성능:
+9.77%
1개월 성능:
+3.06%
6개월 성능:
+60.54%
1년 성능:
+80.15%
1일 변동 폭
$2.27
$2.37
1주일 범위
$2.15
$2.37
52주 변동 폭
$0.8001
$3.39
아네불로 파마슈티컬 Stock (ANEB) Company Profile
명칭
Anebulo Pharmaceuticals Inc
전화
737 203 5270
주소
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
ANEB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
2.36 | 91.62M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.52 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
862.05 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.10 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
아네불로 파마슈티컬 주식(ANEB)의 최신 뉴스
Will Anebulo Pharmaceuticals Inc. stock reach Wall Street targetsQuarterly Investment Review & Community Trade Idea Sharing - Newser
Can Anebulo Pharmaceuticals Inc. stock deliver strong Q4 earningsMarket Volume Summary & Safe Capital Growth Tips - Newser
Anebulo Pharmaceuticals (NASDAQ:ANEB) Trading 0.8% HigherStill a Buy? - MarketBeat
Anebulo Pharmaceuticals (ANEB) Stock Analysis Report | Financials & Insights - Benzinga
Why retail investors pile into Anebulo Pharmaceuticals Inc. stock - BỘ NỘI VỤ
What drives Anebulo Pharmaceuticals Inc stock priceTechnical Resistance Breaks & Exceptional Profit Growth Tips - earlytimes.in
Will Anebulo Pharmaceuticals Inc. stock deliver strong dividend growthPortfolio Return Report & Weekly High Momentum Picks - newser.com
Will Anebulo Pharmaceuticals Inc. stock outperform value stocksJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com
Can Anebulo Pharmaceuticals Inc. stock double in next 5 yearsRate Hike & Risk Managed Investment Entry Signals - newser.com
Will Anebulo Pharmaceuticals Inc. continue its uptrend2025 Market Sentiment & Reliable Price Action Trade Plans - newser.com
Is it too late to sell Anebulo Pharmaceuticals Inc.Gap Up & Reliable Entry Point Trade Alerts - newser.com
Has Anebulo Pharmaceuticals Inc. found a price floorPortfolio Return Report & Long-Term Growth Plans - newser.com
Risk vs reward if holding onto Anebulo Pharmaceuticals Inc.July 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com
How Anebulo Pharmaceuticals Inc. stock valuations compare to rivalsPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com
Is Anebulo Pharmaceuticals Inc. stock supported by strong cash flows2025 Biggest Moves & Long-Term Investment Growth Plans - newser.com
Will Anebulo Pharmaceuticals Inc. stock beat EPS estimates2025 Big Picture & Free High Return Stock Watch Alerts - newser.com
Is Anebulo Pharmaceuticals Inc a good long term investmentEarnings Date Calendar & Outstanding Investment Trading - earlytimes.in
Is Anebulo Pharmaceuticals Inc. stock attractive for ETFsMarket Volume Report & Expert Curated Trade Setup Alerts - newser.com
Quantitative breakdown of Anebulo Pharmaceuticals Inc. recent moveJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com
Anebulo Pharmaceuticals Reports Q1 2026 Financial Results - MSN
[10-Q] Anebulo Pharmaceuticals, Inc. Quarterly Earnings Report | ANEB SEC FilingForm 10-Q - Stock Titan
Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2025 - MarketScreener
Anebulo Pharmaceuticals posts Q1 net loss - MarketScreener
[8-K] Anebulo Pharmaceuticals, Inc. Reports Material Event | ANEB SEC FilingForm 8-K - Stock Titan
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates - Business Wire
Is Anebulo Pharmaceuticals Inc. stock ready for a breakoutProfit Target & Daily Technical Stock Forecast Reports - newser.com
What is the fair value of Anebulo Pharmaceuticals Inc. stock nowJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com
아네불로 파마슈티컬 (ANEB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.18%
0.62%
자본화:
|
볼륨(24시간):